Recent Market News
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Lucid's future growth will be driven by a selection of models on a midsize platform. Lucid Group (NASDAQ: LCID) appears to be one of the benefactors of Tesla's recent stumble and fall. The broader EV industry might be sputtering right now, and investors might be grappling with the impact of tariffs, but Lucid has been on fire, in a good way.
Big names may rule the headlines, but many of the market’s future stars begin as under-the-radar underdogs. While Wall Street focuses on the trillion-dollar club – think the ‘Magnificent 7’ – some of the most compelling opportunities are tucked away in the bargain bin, trading for $5 or less. These low-priced stocks – known as penny stocks – often operate in high-growth corners of the market, and when the right catalyst hits, whether a breakthrough innovation or a disruptive product, they can de
Moleculin Biotech (MBRX) announced the pricing of a public offering consisting of 16,080,000 shares of common stock and Series E warrants to purchase up to 48,240,000 shares of its common stock, at a combined public offering price per share of common stock and accompanying Series E warrants of 37c. The Series E warrants will have an exercise price of 37c per share, are exercisable upon stockholder approval, and will expire five years following the initial exercise date. The offering is expected
Lucas GC (LGCL) announced the pricing of its “best efforts” follow-on offering of 32,150,000 ordinary shares, par value $0.000005 per share, of the Company at a public offering price of 20c per share, for total gross proceeds of $6,430,000 before deducting placement agent’s fee and offering expenses. The Offering is expected to close on or about June 23, 2025, subject to the satisfaction of customary closing conditions. AC Sunshine Securities is acting as the placement agent for the Offering. Pu